Literature DB >> 19141377

Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): lesional cells exhibit an immature dendritic cell phenotype.

Monika E Pilichowska1, Jack L Pinkus, Geraldine S Pinkus.   

Abstract

Histiocytic necrotizing lymphadenitis (HNL) is a rare benign disorder characterized histologically by nodal lesions composed of histiocytes, lymphoid cells, and so-called plasmacytoid T cells/plasmacytoid monocytes, with associated karyorrhexis. It has been proposed that plasmacytoid monocytes represent immature myeloid and lymphoid (plasmacytoid) early-committed dendritic cells (DCs). Monoclonal antibodies are now available for the detection of myeloid (CD1c [BDCA-1]+) and plasmacytoid (CD303 [BDCA-2]+) dendritic cells. With an extensive panel of antibodies to immature and mature DCs and interferon-alpha (IFN-alpha), cryostat section studies of 6 cases of HNL revealed that the morphologically distinctive mononuclear cells in lesional areas consisted of 2 populations of immature DCs: myeloid DCs immunoreactive for CD1c with coexpression of myeloid antigens CD13 and CD33 and plasmacytoid DCs immunoreactive for CD303 and CD123. These cells were CD68+, strongly expressed the IFN-alpha inducible protein MxA, and were nonreactive for fascin, a mature DC marker.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141377     DOI: 10.1309/AJCP7V1QHJLOTKKJ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Kikuchi-fujimoto disease: a study of 24 cases.

Authors:  Divya Supari; Anuradha Ananthamurthy
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-07-24

2.  Repeated Necrotizing Lymphadenitis with MEFV Gene Mutations.

Authors:  Yuta Yamamura; Kengo Furuichi; Tadashi Toyama; Megumi Oshima; Hisayuki Ogura; Koichi Sato; Shiori Nakagawa; Taro Miyagawa; Shinji Kitajima; Akinori Hara; Yasunori Iwata; Norihiko Sakai; Miho Shimizu; Hiroko Ikeda; Tomoko Toma; Kazuya Takasawa; Akihiro Yachie; Takashi Wada
Journal:  Intern Med       Date:  2021-09-11       Impact factor: 1.282

3.  A non-invasive diagnosis of histiocytic necrotizing lymphadenitis by means of gene expression profile analysis of peripheral blood mononuclear cells.

Authors:  Masataka Ishimura; Hiroyuki Yamamoto; Yumi Mizuno; Hidetoshi Takada; Motohiro Goto; Takehiko Doi; Takayuki Hoshina; Shouichi Ohga; Koichi Ohshima; Toshiro Hara
Journal:  J Clin Immunol       Date:  2013-04-23       Impact factor: 8.317

4.  Necrotizing lymphadenitis may be induced by overexpression of Toll-like receptor7 (TLR7) caused by reduced TLR9 transport in plasmacytoid dendritic cells (PDCs).

Authors:  Shigeyuki Asano; Hiroko Sato; Kikuo Mori; Kazuki Yamazaki; Hiroyuki Naito; Hoshiro Suzuki
Journal:  J Clin Exp Hematop       Date:  2021-05-14

5.  Clinicopathological review of immunohistochemically defined Kikuchi-Fujimoto disease-including some interesting cases.

Authors:  Gil Myeong Seong; Jo-Heon Kim; Gil Chai Lim; Jinseok Kim
Journal:  Clin Rheumatol       Date:  2012-08-09       Impact factor: 3.650

6.  Kikuchi-Fujimoto Disease Following COVID-19 Infection in a 7-Year-Old Girl: A Case Report and Literature Review.

Authors:  Yusuke Saito; Yuta Suwa; Yakuto Kaneko; Mitsuhiro Tsujiwaki; Yasuhisa Odagawa
Journal:  Cureus       Date:  2022-07-03

7.  Necrotizing lymphadenitis (NEL) is a systemic disease characterized by blastic transformation of CD8+ cells and apoptosis of CD4+ cells.

Authors:  Shigeyuki Asano; Kikuo Mori; Kazuki Yamazaki; Tetsutaro Sata; Atsushi Kurata; Yuko Sato; Hajime Odajima; Yasushi Akaike; Haruki Wakasa; Masaru Kojima
Journal:  Virchows Arch       Date:  2013-11-30       Impact factor: 4.535

8.  COVID-19 associated Kikuchi-Fujimoto disease.

Authors:  Laura Stimson; Richard Stitson; Maria Bahhadi-Hardo; Edward Renaudon-Smith
Journal:  Br J Haematol       Date:  2021-02-07       Impact factor: 8.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.